These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


224 related items for PubMed ID: 1406858

  • 21. Psychological distress and quality of life associated with genetic testing for breast cancer risk.
    Smith AW, Dougall AL, Posluszny DM, Somers TJ, Rubinstein WS, Baum A.
    Psychooncology; 2008 Aug; 17(8):767-73. PubMed ID: 17992698
    [Abstract] [Full Text] [Related]

  • 22. Psychological impact of genetic testing for hereditary nonpolyposis colorectal cancer.
    Gritz ER, Peterson SK, Vernon SW, Marani SK, Baile WF, Watts BG, Amos CI, Frazier ML, Lynch PM.
    J Clin Oncol; 2005 Mar 20; 23(9):1902-10. PubMed ID: 15774782
    [Abstract] [Full Text] [Related]

  • 23. Predictive testing for Huntington disease in Canada: the experience of those receiving an increased risk.
    Bloch M, Adam S, Wiggins S, Huggins M, Hayden MR.
    Am J Med Genet; 1992 Feb 15; 42(4):499-507. PubMed ID: 1535177
    [Abstract] [Full Text] [Related]

  • 24. Impact of presymptomatic genetic testing for hereditary ataxia and neuromuscular disorders.
    Smith CO, Lipe HP, Bird TD.
    Arch Neurol; 2004 Jun 15; 61(6):875-80. PubMed ID: 15210524
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Screening and preventive behaviors one year after predictive genetic testing for hereditary nonpolyposis colorectal carcinoma.
    Collins V, Meiser B, Gaff C, St John DJ, Halliday J.
    Cancer; 2005 Jul 15; 104(2):273-81. PubMed ID: 15948171
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Attitudes toward direct predictive testing for the Huntington disease gene. Relevance for other adult-onset disorders. The Canadian Collaborative Group on Predictive Testing for Huntington Disease.
    Babul R, Adam S, Kremer B, Dufrasne S, Wiggins S, Huggins M, Theilmann J, Bloch M, Hayden MR.
    JAMA; 1993 Nov 17; 270(19):2321-5. PubMed ID: 8230594
    [Abstract] [Full Text] [Related]

  • 34. Adverse psychological events occurring in the first year after predictive testing for Huntington's disease. The Canadian Collaborative Study Predictive Testing.
    Lawson K, Wiggins S, Green T, Adam S, Bloch M, Hayden MR.
    J Med Genet; 1996 Oct 17; 33(10):856-62. PubMed ID: 8933341
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Short-term psychological impact of predictive testing for Machado-Joseph disease: depression and anxiety levels in individuals at risk from the Azores (Portugal).
    Gonzalez C, Lima M, Kay T, Silva C, Santos C, Santos J.
    Community Genet; 2004 Oct 17; 7(4):196-201. PubMed ID: 15692194
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Genetic Counselling for Predictive Testing in Huntington's Disease in One Centre since 1993. Gender-Specific Aspects of Decision-Making.
    Arning L, Witt CN, Epplen JT, Stemmler S.
    J Huntingtons Dis; 2015 Oct 17; 4(1):87-98. PubMed ID: 26333260
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 12.